NATIVE (non-contrast angiography of the arteries and veins) is a contrast-free MR angiography technique designed to visualize vascular structures throughout of the body. Tailored protocols for use in renal arteries and peripheral vessels are available within the protocol tree provided by Siemens Healthineers. syngo NATIVE TrueFISP is based on the TrueFISP (true fast imaging with steady state precession) sequence, a balanced steady-state gradient echo technique. The sequence can be made selective for arteries or veins by appropriate positioning of the inversion pulse, which can be positioned independently from the imaging volume. The most robust method of performing syngo NATIVE TrueFISP is with respiratory triggering. With BioMatrix Technology, the respiratory sensor in the BioMatrix spine coil improves the workflow and increases efficiency.

syngo NATIVE TrueFISP Non-Contrast MR Angiography: Pulmonary Arteries. See how Marcelo Fernandes Arêas (Siemens Healthineers) does it:
marketing.webassets.siemens-healthineers.com/f735022ac942...

#MRI #MRA #RadSky #MagnetomWorld
@banksgaia.bsky.social

Artificial intelligence (AI) is emerging as a powerful ally in cardiac MRI, addressing many of the challenges that previously limited its efficiency and accessibility. By automating and optimizing steps from protocol planning and image acquisition to reconstruction, analysis, and integration with clinical data, AI can make cardiac MRI faster, more consistent, and more widely available. Far from replacing clinicians, AI supports them by reducing repetitive tasks, improving reproducibility, and enabling the extraction of advanced diagnostic and prognostic information. An important aspect of this evolution is the integration of cardiac MRI into a multimodality framework where it is combined with other imaging techniques such as echocardiography or CT, and with clinical, biological, and electrophysiological data. This approach paves the way for advanced concepts like the digital twin – a virtual model of the patient’s heart that can guide diagnosis and therapy planning, further enhancing precision and personalization in cardiovascular care. The authors explore how AI is transforming their cardiac MRI practice in four main domains: 1. Planning and acquisition: including automated plane prescription and parameter optimization 2. Image reconstruction: accelerating acquisitions and improving image quality 3. Image analysis and post-processing: enabling rapid and consistent quantification 4. Development of diagnostic and prognostic tools: integrating imaging with multisource and multimodal patient data

From Acquisition to Analysis: How #AI is Revolutionizing Cardiac #MRI
by Solenn Toupin, PhD and Théo Pezel, MD, PhD (Lariboisière Hospital, Paris, France).

Learn more: marketing.webassets.siemens-healthineers.com/2dc76fc4bf87...

#CardioSky #WhyCMR #MagnetomWorld #SCMR2026
@banksgaia.bsky.social

Shoutout to Heike Weh for scanning the tree!

Merry Christmas to everyone who celebrates.
Thank you all for the exchanges and collaborations this year, wishing you a restful and joyful holiday season.
#MagnetomWorld #MRI #RadSky

Photon-counting CT (PCCT) represents a major step toward bridging the historical gap between cardiac CT and CMR. Its ability to provide high-resolution anatomical imaging, quantitative spectral data, and myocardial tissue characterization within a single, time-efficient acquisition brings cardiac CT closer to the comprehensive diagnostic capability traditionally reserved for CMR. However, these modalities should not be seen as competing but as highly complementary. CMR remains the reference standard for advanced tissue characterization, myocardial fibrosis assessment, and complex flow quantification, while PCCT offers unparalleled spatial resolution, reduced acquisition times, and simultaneous evaluation of coronary arteries, myocardium, and valves. Together, PCCT and CMR form a synergistic imaging approach, combining structural and functional insights to refine diagnosis, guide management, and ultimately improve patient care in cardiovascular disease. Shoutout to the co-authors: Adrien De Minteguiaga, M.D.; Christos Gkizas, M.D., Ph.D.; Aimée Rodriguez Musso, M.D.; Mehdi Haidar, M.D.

Cardiovascular Applications of Photon-Counting CT: When Cardiac CT Meets Cardiac MR by Benjamin Longère, François Pontana, et al. (@chulille.bsky.social).

Learn more: marketing.webassets.siemens-healthineers.com/72eb9444c690...

#CardioSky #MRI #RadSky #MagnetomWorld #CMR @banksgaia.bsky.social

MRI-Guided Planning for Pelvic Brachytherapy By Florian Putz, M.D. (Department of Radiation Oncology, Universitätsklinikum Erlangen, FAU Erlangen-Nürnberg, Erlangen, Germany) At University Hospital Erlangen, Germany, MRI plays a central role in the planning of pelvic brachytherapy. After applicator implantation, a planning MRI is performed on the 1.5T MAGNETOM Sola RT Pro Edition, which is conveniently located within the radiation oncology department. This setup enables streamlined workflow between the procedure area and the HDR treatment rooms. The MR-in-RT working group at University Hospital Erlangen shares their MRI protocols for pelvic brachytherapy. Developed in accordance with the GEC-ESTRO recommendations, these protocols include 3D sequences such as T2-SPACE and T1-VIBE Dixon. Together, they provide excellent visualization of the target volume, organs at risk, and applicators, supporting accurate and reproducible treatment planning.

MRI-Guided Planning for Pelvic #Brachytherapy by Dr. Florian Putz (@fau.de).

Download 1.5T cervix and prostate protocols (.exar1) at:
www.magnetomworld.siemens-healthineers.com/clinical-cor...

#MRI #OncoSky #MRinRT #ProstateCancer #CervicalCancer #Radiotherapy #GECESTRO #MagnetomWorld #RadSky

Diffusion MRI of the human heart provides unique insight into myocardial microstructure but has been hampered by cardiac and respiratory motion, short T2 of the heart muscle, and limited gradient strength. Recent advances in ultra-strong gradient technology not only help to overcome these technical challenges but also allow higher diffusion weighting (i.e., b-values) with clinically compatible echo times. The authors demonstrate how this enabled in vivo diffusion kurtosis imaging (DKI) and q-space trajectory imaging (QTI) in the beating human heart, therefore moving beyond the Gaussian assumptions of diffusion tensor imaging (DTI). These advances may pave the way for more sensitive biomarkers of pathological changes of the myocardium and bring microstructural imaging closer to clinical application. Key points • Ultra-strong gradients (300 mT/m) make cardiac diffusion MRI feasible at higher b-values. • In vivo cardiac diffusion kurtosis imaging and q-space trajectory imaging (QTI) were demonstrated with clinically compatible echo times. • Kurtosis and QTI metrics reveal non-Gaussian diffusion, offering access to new imaging biomarkers of myocardial microstructure. • Translation to clinical systems is within reach with new 200 mT/m gradient scanners. Shoutout and thank you to the co-authors: Lars Mueller, Ph.D.; Jürgen E Schneider, Ph.D. (Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK) Derek K Jones, Ph.D. (Cardiff University Brain Research Imaging Centre (CUBRIC), School of Psychology, Cardiff University, Cardiff, UK) Filip Szczepankiewicz, Ph.D. (Department of Medical Radiation Physics, Lund University, Lund, Sweden) Fabrizio Fasano, Ph.D. (Siemens Healthineers)

Unlocking the Heart’s #Microstructure: Cardiac #Diffusion #MRI with Ultra-Strong Gradients by Maryam Afzali, PhD; et al. (@universityofleeds.bsky.social).
marketing.webassets.siemens-healthineers.com/0267aa50bc95...

@deekayjay.bsky.social
#dMRI #RadSky #CardioSky #MagnetomWorld

This issue covers a broad spectrum of innovation: from the potential of ultra-high-gradient MRI to the advantages of lower-field MRI for imaging claustrophobic patients and those with implants; from ultra-fast pediatric brain MRI to standardized pelvic protocols; and from improving access to care with mobile MRI to tackling the real-life challenges of operating MRI systems in geographically challenging or remote locations. The motto of this year’s RSNA — “Imaging the Individual – Fuel Curiosity, Ignite Inspiration – Fresh Insights, New Frontiers – Global Reach, Limitless Potential” — is fully reflected in the articles featured in this edition.

With #RSNA2025 just days away, now’s the perfect time to explore the latest edition of MAGNETOM Flash at www.magnetomworld.siemens-healthineers.com/publications...

Shoutout to all contributors and to the team behind the amazing content on #MagnetomWorld

#RadSky #NeuroSky #OncoSky #MRI

Advances in Ultra-High-Gradient MRI: High-Resolution Imaging for Accurate Diagnosis of Pancreatic Cystic Lesions by Liang Zhu, M.D.; et al. (Peking Union Medical College Hospital, Beijing, China). Pancreatic cystic lesions (PCLs) are increasingly detected in clinical practice, largely due to the widespread use of computed tomography (CT) and magnetic resonance imaging (MRI). These lesions encompass a broad spectrum of diseases with similar imaging features, ranging from non-neoplastic cysts and benign tumors to premalignant and frankly malignant neoplasms. Accurate diagnosis is therefore challenging. Benign lesions may be misinterpreted as malignancies, leading to overtreatment, while early-stage cancer may go undetected, delaying appropriate treatment. MRI offers distinct advantages for the evaluation of PCLs, including noninvasiveness, absence of ionizing radiation, superior soft-tissue contrast, and multiparametric imaging capabilities. Moreover, high-resolution MRI enabled by an ultra-high-gradient system and deep-learning reconstruction delineates subtle internal structures of PCLs and provides critical diagnostic clues. 👏 Shoutout to the co-authors: Bowen Wu, Yitong Lu (Department of Radiology, Peking Union Medical College Hospital, Beijing, China) Yueluan Jiang, Xiaoye Wang (Siemens Healthineers Ltd., Beijing, China)

Advances in Ultra-High-Gradient #MRI: High-Resolution Imaging for Accurate Diagnosis of Pancreatic Cystic Lesions
by Liang Zhu, MD; et al. (PUMC Hospital, Beijing, China).

Learn more: marketing.webassets.siemens-healthineers.com/8d6fae1515f7...

#RadSky #OncoSky #MagnetomWorld #SiemensHealthineers

DANTE Pulse Changed Our Clinical Routine and Research by Yasutaka Fushimi, MD, PhD; et al. (Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan) Vessel wall MRI (VW-MRI) has become an essential tool for characterizing pathological features of the vessel wall in clinical practice. Its clinical importance is well established in evaluating atherosclerotic disease, both extracranially and intracranially. With the introduction of additive pre-pulses such as motion-sensitized driven equilibrium (MSDE) and delay alternating with nutation for tailored excitation (DANTE), VW-MRI has expanded its potential applications beyond atherosclerosis and has improved the assessment of atherosclerotic lesions. While MSDE is widely used, its low diffusion-sensitizing capability can cause blurring and T2-weighted effects. In contrast, the DANTE pulse attenuates signals from flowing spins by applying a train of low flip-angle pulses along the flow direction, resulting in less attenuation of signals from static tissue. The authors have encountered various clinical cases in which non-contrast and contrast-enhanced DANTE T1-SPACE imaging helped visualize abnormal findings. This review presents representative cases acquired on a 3T scanner, illustrating the clinical utility of DANTE T1-SPACE imaging. Shout-out to the co-authors: Sachi Okuchi, Akihiko Sakata, Satoshi Nakajima, Takayuki Yamamoto, John Grinstead, Sinyeob Ahn, Yuji Nakamoto

DANTE Pulse Changed Our Clinical Routine and Research by Yasutaka Fushimi, MD, PhD; et al. (Kyoto University, Japan).

Learn more: marketing.webassets.siemens-healthineers.com/bedfcb025ca7...

#MRI #RadSky #Stroke #MagnetomWorld #VesselWallImaging

Join @deekayjay.bsky.social and me for a live webinar on the ecucational content of #MagnetomWorld.

📅 Date: Monday October 27th
🕒 Time: 17:00 CET / 15:00 UTC
📍 Join us: www.magnetomworld.siemens-healthineers.com/clinical-cor...

#MRI #RadSky #DemocratizingMRI #Education #Imaging

We are excited to share the new interventional radiology edition of MAGNETOM Flash, launched for #CIRSE2025.

📖 Read the full issue here: www.magnetomworld.siemens-healthineers.com/publications...

Shoutout to all contributers!

#MRI #RadSky #InterventionalRadiology #iMRI #MagnetomWorld

The images show sports (tennis, cycling, football) as MR images.

Looking for conversation-starting wall art?
Heike Weh (Siemens Healthineers) made MRI-based sports images that capture the human body in motion.
They are available for download at www.magnetomworld.siemens-healthineers.com/magnetom-mat...

#MagnetomWorld #MRI #MedicalImaging #Radiology #RadSky

Liver cancer is one of the fastest-growing cancers and a major contributor to cancer-related mortality. Minimally invasive, nonsurgical local liver therapies play a key role in appropriately selected patients with hepatobiliary cancer. Magnetic resonance imaging (MRI) offers a compelling solution for liver interventions by providing multiplanar, real-time needle guidance without exposure to ionizing radiation. It has excellent soft tissue contrast, outstanding spatial and temporal resolution, and functional imaging capabilities like diffusion-weighted imaging. Additionally, real-time temperature measurement during liver ablation helps to ensure complete tumor destruction while preserving surrounding healthy tissue and thus minimizing collateral damage The integration of MRI guidance into hepatobiliary cancer diagnosis and treatment marks a significant advancement in interventional oncology. Its unique qualities enhance precise and safe planning, execution and monitoring of liver biopsies, liver tumor ablation, and percutaneous biliary drainage. Shoutout and thank you to the coauthors: Marcel Gutberlet, Dominik Horstmann, Julian Glandorf, Bennet Hensen, Frank Wacker Forschungscampus STIMULATE, Otto-von-Guericke Universität, Magdeburg, Germany / Department of Radiology, Hannover Medical School, Hannover, Germany

Interventional #MRI in the Liver: Why, When, and Where?
By Daniel Düx, MD; et al. ( @uni-magdeburg.de / Hannover Medical School, Germany).
🔗 marketing.webassets.siemens-healthineers.com/d67d220657dd...

#iMRI #interventionalRadiology #LiverBiopsy #MagnetomWorld #ImageGuidedTherapy #RadSky #MedSky

Liver biopsy and thermal ablation of liver tumors are well-established procedures, typically performed under CT or ultrasound (US) guidance. However, small tumors are barely visible (especially on CT imaging), and unfavorable localizations for CT and US guidance (e.g., in the liver dome) increase the risk of sampling errors or incomplete ablation. For liver tumors < 3 cm in size, a sampling error of around 20% has been published. Furthermore, biopsy under CT guidance bears the risk of X-ray exposure, especially for the interventional radiologist. MRI provides a high soft tissue contrast that can even be enhanced for a prolonged period with hepatocyte-specific contrast agents. This enables better visualization of liver tumors than with CT or US imaging, where contrast enhancement is limited to a short period of time during the contrast agent administration. Furthermore, the slice orientation can be chosen freely in MRI. This allows a slice orientation along the needle trajectory, displaying needle and target within the slice regardless of the complexity of the angulation. MRI can be performed as fluoroscopic imaging with a fast frame rate of less than one second per image. Even an alternating display of the needle path in perpendicular projections is possible. As a consequence, small lesions and oblique needle access do not represent a limitation for biopsy or ablation under MRI guidance. With regard to liver biopsies, clinical success rates of around 90% for MRI-guided biopsies were described in some early studies, and, in some smaller case series, they were even higher (> 90%). Shoutout and thank you to the co-authors: Matthias Fabritius, M.D. and Jens Ricke, M.D.

MRI-Guided vs. CT-Guided Interventions: A Focus on the Liver by Max Seidensticker, M.D.; et al. (@lmuradiology.bsky.social, Munich, Germany).
🔗 marketing.webassets.siemens-healthineers.com/2f40dcbe0e82...

#MRI #InterventionalRadiology #LiverBiopsy #MRIguidedIntervention #RadSky #MagnetomWorld

The Role of Cardiac Magnetic Resonance Imaging in Valvular Heart Disease. A Scientific Literature Review by Thomas Treibel, PhD; et al. (Institute of Cardiovascular Science, University College London, London, UK / Barts Heart Centre, St. Bartholomew’s Hospital, Barts Health, London, UK). Valvular heart disease (VHD) is becoming increasingly prevalent, affecting up to 50% of the population aged over 65. Echocardiography is the first-line imaging test in VHD, for surveillance and assessment of valve anatomy for pre-procedural planning. Cardiac computed tomography (CT) has also become essential in planning transcatheter interventions. However, cardiovascular magnetic resonance (CMR) provides a comprehensive assessment of the valve morphology, lesion severity, ventricular remodeling, and extracardiac abnormalities such as aortopathy. CMR is an important, complementary modality to echocardiography in patients with VHD. It offers a comprehensive all-in-one solution for assessing the valves, the vasculature, and the myocardial response to valvular insult, and excels in challenging clinical scenarios such as mixed or multiple valve lesions. This review explores the value of CMR in the assessment of VHD. Shoutout to the co-authors: Nikoo Aziminia, Jonathan Bennett, Iain Pierce, and George Thornton

The Role of #CMR in Valvular Heart Disease. A Scientific Literature Review by Thomas Treibel, PhD; et al. (UCL / Barts Heart Centre, London, UK).

🔗 marketing.webassets.siemens-healthineers.com/9f382b65996a...

#MagnetomWorld #MRI #CardioSky #WhyCMR #VHD @banksgaia.bsky.social

Lower extremity arterial disease (LEAD) is often associated with serious comorbidities that significantly reduce both quality of life and life expectancy. Early detection and treatment are therefore essential to reduce cardiovascular mortality. Treatment options for LEAD include conservative therapy, endovascular interventions, and open surgical procedures. According to the 2017 ESC guidelines, endovascular therapy for stenosis or occlusion of the iliac system measuring less than 5 cm provides good long-term revascularization outcomes with low complication rates; and in the femoro-popliteal region, endovascular treatment is recommended for lesions shorter than 25 cm. Regular follow-up of patients after stent implantation is critical. Given that nearly half of LEAD patients also suffer from renal impairment, the use of nephroprotective imaging modalities may be important during follow-up. One such alternative is non-contrast quiescent-interval single-shot MR angiography (QISS MRA). Read how the type and location of different arterial stents implanted in the iliac and femoro-popliteal regions affect the image quality of QISS MRA scans.

Image Quality of QISS #MRA with Different Stent Types by Ferenc Imre Suhai, MD; et al. (Heart and Vascular Centre, Semmelweis Univ., Budapest, Hungary).

marketing.webassets.siemens-healthineers.com/9756daa5b64e...

#MRI #VascularImaging #NonContrastImaging #MagnetomWorld @banksgaia.bsky.social

ESOC 2025 is in full swing in Helsinki. Don’t miss the 2025 edition of “The Role of Imaging Along the Stroke Pathway”, featuring an editorial by Professor Riitta Rautio (Turku University Hospital and University of Turku, Finland). This issue explores imaging across the entire stroke pathway – from prevention, through acute stroke imaging and therapy, to perfusion evaluation and angiography. 👏 Huge thanks to all contributing authors and co-authors: Qi Yang, Luigi Cirillo, Zihao Zhang, Marios Psychogios, Patricia Maishi, Vincent Dunet, Stephen Cauley, John Conklin, Fabrizio Esposito, Philipe Breiding, Adnan Mujanovic, Rahul Kumar, Pierre-Julien Bruyère, Minghua Sun, et al.

Don’t miss the 2025 edition of “The Role of Imaging Along the Stroke Pathway” at #ESOC25 in Helsinki!
From prevention through perfusion & angiography to therapy — this issue has it all.
marketing.webassets.siemens-healthineers.com/97e49a46b4b4...

#MRI #NeuroSky #RadSky #Stroke #MagnetomWorld

Integrating SAMER Retrospective Motion Correction into 3D Deep Learning Image Reconstruction for High-Quality, Fast, and Robust Brain MRI by Daniel Polak (Siemens Healthineers, Erlangen, Germany), et al. Patient motion is one of the most common sources of image degradation in clinical neuroimaging, manifesting as blurring, ringing, or in severe cases ghosting/folding artifacts. Radiologists are often forced to either interpret images despite these artifacts – risking missed or misinterpreted pathologies – or to request costly and time-consuming repeat scans. In pediatric patients, motion is typically more severe, often necessitating anesthesia, which increases both procedural risks and costs. Motion artifacts also reduce the reliability of automated quantitative clinical tools, such as those used for brain morphometry and the identification or segmentation of hemorrhages, edema, and tumors. Such tools are increasingly important in the screening, monitoring, and treatment of neurodegenerative diseases such as Alzheimer’s. Scout Accelerated Motion Estimation and Reduction (SAMER) is a retrospective motion correction technique for brain imaging that enables fast motion estimation and artifact correction without the need for external tracking hardware. Clinically evaluated in both adult and pediatric patient populations, SAMER has significantly reduced the number of non-diagnostic motion cases. More recently, SAMER has been integrated into a deep learning-based image reconstruction framework to support highly accelerated, motion-robust 3D brain imaging. In this article, the authors review the combined DL-SAMER technique and demonstrate its effectiveness in vivo using MPRAGE and SPACE acquisitions at R = 6 acceleration. Shout out to the co-authors: Dominik Nickel, Daniel Nicolas Splitthoff, Bryan Clifford, Yan Tu Huang, Wei-Ching Lo, Shohei Fujita, Susie Y. Huang, John Conklin, Lawrence L. Wald, Stephen Cauley

DL-SAMER: A new deep learning + retrospective motion correction method for fast, motion-robust 3D brain #MRI — effective even in challenging pediatric cases.
Check it out 👉 marketing.webassets.siemens-healthineers.com/7a1c195a6a39...

#NeuroSky #RadSky #MagnetomWorld
@harvardmed.bsky.social

Integrating MRI into Radiotherapy: Insights from Clinical Implementation of an MRI-Guided Workflow for Prostate Cancer by Philipp Schubert, M.D; Florian Putz, M.D.; et al. (Department of Radiation Oncology, Universitätsklinikum Erlangen, FAU Erlangen-Nürnberg, Erlangen, Germany) Integrating MRI into radiotherapy (RT) planning has significantly advanced prostate cancer treatment. Superior soft tissue contrast enables precise delineation of the prostate, accurate identification of dominant intraprostatic lesions, and clear differentiation of surrounding organs—resulting in highly personalized treatment strategies. At the Department of Radiation Oncology, Universitätsklinikum Erlangen, a combined MRI planning and RT treatment planning workflow has been developed. It includes standardized patient preparation, dedicated imaging in the treatment position, synthetic CT, and deep learning postprocessing. While implementing the comprehensive MR-guided planning protocol, the team learned to optimize multiple aspects, including: - Changing the medium used for filling the rectal balloon - Avoiding fiducial marker implantation prior to MRI - Implementing an in-house solution for reversed gradient polarity correction of single-shot EPI sequences The recent incorporation of MR-based pelvic OAR autocontouring has considerably reduced clinical workload and is particularly promising for MR-only workflows. Combining RT-optimized MRI with #AI postprocessing applications could be crucial in facilitating advanced MR-guided treatment concepts such as focal dose boost and neurovascular sparing.

Integrating #MRI into #Radiotherapy for #ProstateCancer:
Putz et al. @fau.de share their MRI-guided RT workflow—incl. synthetic CT, MR-based OAR autocontouring & AI postprocessing.
📄 marketing.webassets.siemens-healthineers.com/b0530f15a0c0...

#OncoSky #MedPhys #MagnetomWorld #SiemensHealth

Body Imaging at 7T: A Path Toward Clinical Translation by Greg Metzger, Ph.D.; et al. (University of Minnesota Center for Magnetic Resonance Research (CMRR)), Minneapolis, MN, USA. The evolution of ultra-high-field (UHF) magnetic resonance imaging (MRI) at 7 Tesla is gradually unlocking opportunities for high-resolution anatomical and functional imaging of the human torso. Over nearly two decades, progress in radio-frequency (RF) hardware, transmit chain architectures, and electromagnetic field management strategies have addressed many of the challenges associated with transmit B1 (B1+) inhomogeneity and specific absorption rate (SAR) constraints. Key developments include the transition from single-channel to parallel transmit (pTx) systems, the development of multichannel transceiver arrays, and advanced RF shimming and pulse design techniques that balance B1+ efficiency and homogeneity. High-quality images obtained at 7T and 10.5T in the pelvis, abdomen, and chest demonstrate the potential for clinical translation, while ongoing innovations in real-time SAR monitoring, calibration methods, and universal solutions promise to streamline workflows. 7T MRI is poised to transform precision medicine by merging high sensitivity with molecular insights. In this article, the authors review the interplay between technological innovation and anatomy-specific imaging at CMRR, concluding with a roadmap for clinical adoption.

Body #MRI at 7T: A Path Toward Clinical Translation
by Greg Metzger, PhD; et al. (CMRR, University of Minnesota).

🔗www.magnetomworld.siemens-healthineers.com/clinical-corner/case-stu...

#RadSky #UHF #7TMRI #BodyMRI #MagnetomWorld #SiemensHealthineers #PrecisionMedicine #MedPhys

Pregnancy and MRI of the Appendix by Demi van Bijlevelt, M.D.; et al. (Department of Pulmonology, Isala Hospital, Zwolle, the Netherlands) Abdominal pain in pregnant patients poses a diagnostic challenge. Acute appendicitis can occur during pregnancy, just as in any other patient. In contrast to other patients, however, adequate diagnosis and treatment is important to prevent possible complications such as preterm labor. Physical examination and standardized diagnostic procedures — such as abdominal ultrasound — are more difficult because of the growing uterus. Due to the clinical consequences, there is a need for further examination in cases of inconclusive diagnostics. In pregnant patients, MRI may provide a solution. This is a highly reliable tool to primarily unveil signs of acute appendicitis and subsequently determine the need for further treatment. In MRI, various sequences including diffusion-weighted imaging (DWI) and derived apparent diffusion coefficient (ADC) maps are helpful to diagnose acute appendicitis and avoid the need for intravenous contrast. Shoutout to co-authors Eline Valentijn, M.D. (Department of Emergency Medicine, St Jansdal Hospital, Harderwijk, the Netherlands) and Gwen Vuurberg, M.D., Ph.D. (Department of Radiology and Nuclear Medicine, Rijnstate Hospital, Arnhem, the Netherlands) And a big thank you to the Editorial Board at Compendium Medicine for supporting these helpful articles written in the concise Compendium Medicine style!

Pregnancy and MRI of the Appendix
by Demi van Bijlevelt, MD; et al. (Isala Hospital, Zwolle, Netherlands).

Abdominal pain in pregnant patients poses a diagnostic challenge. #MRI can help.

🔗 www.magnetomworld.siemens-healthineers.com/clinical-cor...

#RadSky #EmergencyMedicine #MagnetomWorld #DWI

Advanced Imaging in Cardio-Oncology: Cardiac Magnetic Resonance for Cardiotoxicity Assessment by Federica Brilli, M.D.; Marco Francone, M.D., Ph.D.; et al. (Department of Biomedical Sciences, Humanitas University, Milan, Italy & IRCCS Humanitas Research Hospital, Milan, Italy) Advancements in cancer therapies have significantly improved survival rates, leading to a growing number of cancer survivors. However, this success also brings increased attention to therapy-related side effects—especially cardiovascular complications—which may manifest both acutely and chronically. In 2022, the International Cardio-Oncology Society (IC-OS) introduced a consensus definition for cancer therapy-related cardiac dysfunction (CTRCD), which includes conditions such as cardiomyopathy, heart failure (HF), myocarditis, vascular toxicity, hypertension (HTN), arrhythmias, and QT interval prolongation associated with anticancer treatments. This comprehensive framework aims to address long-standing issues of misclassification and misdiagnosis in the field. That same year, the European Society of Cardiology (ESC) published its first cardio-oncology guidelines, setting international standards for diagnosing and managing cancer therapy-related cardiovascular toxicity (CTR-CVT). This initiative involved collaboration with the European Hematology Association (EHA), the European Society for Radiotherapy and Oncology (ESTRO), and the International Cardio-Oncology Society, underscoring the need for a systematic approach to managing cardiovascular toxicities in cancer patients. The ESC guidelines emphasize early detection, risk assessment, and preventive measures to improve outcomes for this at-risk population. Learn how cardiac magnetic resonance (CMR) has become an essential tool in the early detection and management of chemotherapy-induced cardiotoxicity, offering significant financial, operational, and clinical advantages

#CMR is key in detecting chemo-induced #cardiotoxicity — offering clinical & economic value.
ESC & IC-OS guidelines push for early detection in #CardioOncology.
📖 Read more: www.magnetomworld.siemens-healthineers.com/clinical-cor...

#CardioSky #MRI #OncoSky @banksgaia.bsky.social #MagnetomWorld

Fast Abdominal MRI with Deep Learning Reconstruction: Practical Experience from Zhongshan Hospital by Mengsu Zeng, MD; Shengxiang Rao, MD; et al. (Zhongshan Hospital, Fudan University, Shanghai Institute of Medical Imaging, Shanghai, China) Abdominal MRI is a key diagnostic modality for evaluating liver, biliary, and pancreatic diseases—its image quality directly impacting diagnostic accuracy. Deep learning-based image reconstruction (DLR) significantly reduces acquisition time while maintaining or enhancing image quality through optimized image acquisition, reconstruction, and denoising. In this article the authors share their practical experience in applying Deep Resolve technology to abdominal MRI, covering T2-weighted imaging (T2WI), magnetic resonance cholangiopancreatography (#MRCP), and diffusion-weighted imaging (DWI). Reduced acquisition times not only increase scanner throughput and reduce operational costs, but also improve patient comfort and minimize motion artifacts.

Fast Abdominal #MRI with Deep Learning Image Reconstruction. Cuts scan time, improves image quality & boosts patient comfort. Covers T2WI, #MRCP & DWI.

Read more: marketing.webassets.siemens-healthineers.com/fce0d2bcf600...

#MagnetomWorld #DeepResolve #Radiology #FastMRI #AI #MedSky #OncSky

MRI of the lacrimal channel in cats offers new opportunities for diagnosing and managing lacrimal system diseases. MRI enables detailed evaluation of pathological obstructions in the lacrimal system, supporting veterinarians in making accurate diagnoses and determining the most appropriate treatment strategies. The potential benefits of this imaging method include: - Accurate diagnosis and treatment planning: High-resolution imaging provides critical information about the location, cause, and severity of obstructions, enabling veterinarians to decide on the most suitable treatment approach, such as surgical intervention, stent placement, or conservative management. - Prevention of unnecessary interventions: Helps identify patients who do not need surgical or stent procedures, thereby avoiding unnecessary invasive interventions. This reduces stress, recovery time, and costs for both patients and pet owners. - Improved workflow and ease of intervention: Detailed imaging supports better planning and execution of interventions, increasing workflow efficiency. - Better outcomes: Accurate diagnosis and targeted treatment can lead to shorter recovery times and improved treatment success rates. - Development of new treatment approaches: This imaging method contributes to a better understanding of lacrimal system diseases, paving the way for the development of novel treatment approaches in the future.

Lacrimal Channel #MRI in Cats
by Selim Akkoyunlu, @vetbbc.bsky.social, et al. (İstanbul Hayvan Hastanesi / HS Veteriner Kliniği, Türkiye).

📖 Read the full case report: marketing.webassets.siemens-healthineers.com/380d61df0f8d...

#VetMedSky #VetSky #Imaging #MagnetomWorld #VeterinaryRadiology

Introducing a set of advanced 3T #MRI protocols designed to achieve high-quality diagnostic imaging with significantly reduced acquisition times. Enabled by Deep Resolve, the AI-powered image reconstruction technology, these protocols deliver high-quality scans in approximately three minutes across a wide range of anatomical regions. Developed and meticulously evaluated by Dr. Seong-ho Lee of Leaders Radiology Hospital in Seoul, these protocols integrate deep learning technology to enhance imaging efficiency while maintaining diagnostic detail. By reducing scan times, they improve workflow efficiency and patient experience without compromising image quality.

Unrivaled Speed in #MRI: The Deep Resolve Protocols by Dr. Seong-ho Lee (Leaders Radiology Hospital, Seoul, Republic of Korea).
Download a set of advanced 3T MRI protocols (.exar1) at www.magnetomworld.siemens-healthineers.com/clinical-cor...

#RadSky #NeuroSky #MSK #AI #MagnetomWorld

The picture shows the cover of the MR Glossary. A Dictionary of Magnetic Resonance.

The new, extended edition of the MR Glossary is here! Explore definitions and explanations on (almost) everything MRI-related in English, Chinese, French, Spanish, or German.
www.magnetomworld.siemens-healthineers.com/publications...

#MagnetomWorld #MRI #RadSky #NeuroSky #CardioSky

Treatment protocols for glial brain tumors have remained largely unchanged over the past decades, with neurosurgery serving as the cornerstone of initial treatment, followed by radio- and pharmacotherapy. In neurosurgery, technological advances like intraoperative MR imaging (ioMRI) have made it possible to push the boundaries and maximize the extent of resection, which is linked to improved patient prognosis and survival. The study compared the extent of resection in glioblastoma patients with and without ioMRI, and the association of ioMRI with the incidence of adverse events. A total of 406 patients with histologically confirmed WHO grade 4 glioblastoma tumors were retrospectively included; 74 patients were undergoing clinically and surgically indicated ioMRI. The study shows that in this patient cohort, the use of ioMRI led to substantially enhanced rates of gross total resection without an increased risk of postoperative adverse events.

The Effect of Intraoperative #MRI on Extent of Resection and Adverse Events in High-Grade Glial Tumors by Luis Padevit, MD; et al. (University Hospital Zurich, Switzerland).
marketing.webassets.siemens-healthineers.com/3db377bf4e5d...

#MagnetomWorld #NeuroSky #ioMRI #Neurosurgery #BrainTumor

This article is by Andreas Voskrebenzev, Ph.D.; Filip Klimeš, Ph.D.; and Jens Vogel-Claussen, M.D. (Hannover Medical School and BREATH - Biomedical Research in End-Stage and Obstructive Lung Disease (BREATH), Member of the Deutsches Zentrum für Lungenforschung (DZL), Hannover, Germany). Chronic pulmonary diseases —such as chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and chronic thromboembolic pulmonary hypertension (CTEPH) – require accurate and sensitive diagnostic techniques to monitor progression and therapeutic response. Traditional pulmonary function tests (PFTs), including the Tiffeneau-Pinelli index, provide global lung function parameters but lack the capacity to map region-specific changes. Imaging approaches like computed tomography (CT) or single photon emission computed tomography (SPECT) can visualize lung morphology and function but inevitably involve ionizing radiation, making repeated examinations challenging. Magnetic resonance imaging (MRI) offers a promising, radiation-free alternative for lung function assessment. PREFUL MRI provides a robust, radiation-free means of assessing ventilation and perfusion in a single free-breathing scan. Validation studies have consistently shown strong concordance with established methods like SPECT, DCE, and hyperpolarized gas MRI, underscoring its clinical potential. PREFUL technology will be available soon under the product name LungMaps as a postprocessing application for MRI scanners from Siemens Healthineers.

Phase-Resolved Functional Lung (PREFUL) #MRI: The Next-Generation Ventilation-Perfusion Scan?
Learn more about the radiation-free alternative for lung function assessment at www.magnetomworld.siemens-healthineers.com/clinical-cor...

#MagnetomWorld #LungHealth #LungFunctionMonitoring

Lumbar spinal stenosis (LSS) is one of the most common degenerative conditions in adults, with approximately 200,000 new diagnoses annually in the United States. Magnetic resonance imaging (MRI) plays a pivotal role in diagnosing and grading LSS, radiologists must routinely evaluate multiple lumbar levels to check for narrowing at the spinal canal, lateral recesses, and neural foramina. Despite the critical role, MRI-bases LSS reporting remains a time-intensive and repetitive task for radiologists, often compounded by poor interobserver agreement in stenosis grading. To address these challenges, a multidisciplinary team from the National University Hospital (NUH) in Singapore, the National University of Singapore (NUS), and external collaborators developed Spine AI, a deep learning (DL) solution designed to streamline LSS evaluation. This article explores the journey of developing and integrating an AI-based standalone solution for lumbar spinal stenosis—illustrating how research, clinical expertise, and industry collaboration can align to transform clinical care. As the model evolves, future capabilities may include detecting additional spinal pathologies, analyzing the cervical spine, and identifying metastatic lesions. AI-based tools are poised to become indispensable in everyday radiology. The successful deployment of the Spine AI model as a research application on syngo.via Frontier, backed by a technology development agreement, highlights the practical application of academic AI research in everyday clinical practice and paves the way for further interdisciplinary efforts to improve patient care. Please note that MR Lumbar Spine AI is currently under development and not commercially available. It is for research use only. Not for clinical use. It is not for sale in the USA and its future availability cannot be ensured.

From Concept to Deployment: A Deep Learning Model for Lumbar Spinal Stenosis by James Hallinan, MBChB, FRCR; et al. (National University Hospital, Singapore).
marketing.webassets.siemens-healthineers.com/56e5478aaac1...

#MRI #NeuroSky #AI #DeepLearning #MagnetomWorld #MSK #Spine

Kidney transplantation is the therapy of choice for patients with end-stage chronic kidney disease. Close monitoring of renal allografts post-surgery is crucial for early detection of dysfunction. Functional imaging with #MRI helps characterize function parameters and detect changes. Diffusion tensor imaging (#DTI) has been used in assessing renal damage of chronic parenchymal diseases and diabetic nephropathy. In this case, the authors used DTI and tractography in assessing the function of renal allograft at an early stage after transplantation. The figure shows a healthy volunteer with no history of renal disease, hypertension, diabetes, or other vascular diseases.

On todays #WorldKidneyDay I'd like to highlight Assessment of Renal Allograft Function with #DTI and Tractography by Wen Shen, MD (Tianjin First Center Hospital, China).
marketing.webassets.siemens-healthineers.com/37c110a19097...

📌 The Figure shows a healthy volunteer.
#MRI #MagnetomWorld #RadSky